First Time Loading...
C

China National Accord Medicines Corp Ltd
SZSE:000028

Watchlist Manager
China National Accord Medicines Corp Ltd
SZSE:000028
Watchlist
Price: 35.13 CNY 0.92% Market Closed
Updated: Apr 30, 2024

China National Accord Medicines Corp Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

China National Accord Medicines Corp Ltd
Revenue Peer Comparison

Comparables:
1099
S
601607
600998
C
600511
000963

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
C
China National Accord Medicines Corp Ltd
SZSE:000028
Revenue
¥75.5B
CAGR 3-Years
8%
CAGR 5-Years
12%
CAGR 10-Years
14%
Sinopharm Group Co Ltd
HKEX:1099
Revenue
¥591.6B
CAGR 3-Years
11%
CAGR 5-Years
12%
CAGR 10-Years
15%
S
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Revenue
¥260.3B
CAGR 3-Years
11%
CAGR 5-Years
10%
CAGR 10-Years
13%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Revenue
¥151.8B
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
17%
C
China National Medicines Corp Ltd
SSE:600511
Revenue
¥49.7B
CAGR 3-Years
7%
CAGR 5-Years
5%
CAGR 10-Years
17%
Huadong Medicine Co Ltd
SZSE:000963
Revenue
¥40.3B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
10%

See Also

What is China National Accord Medicines Corp Ltd's Revenue?
Revenue
75.5B CNY

Based on the financial report for Dec 31, 2023, China National Accord Medicines Corp Ltd's Revenue amounts to 75.5B CNY.

What is China National Accord Medicines Corp Ltd's Revenue growth rate?
Revenue CAGR 10Y
14%

Over the last year, the Revenue growth was 3%. The average annual Revenue growth rates for China National Accord Medicines Corp Ltd have been 8% over the past three years , 12% over the past five years , and 14% over the past ten years .